Skip to main content
Premium Trial:

Request an Annual Quote

Publishers' Views on PRISM

Alex Palazzo on The Daily Transcript posted some publishers' reactions to PRISM's anti-open access stance -- they don't like it. Rockefeller's Mike Rossner asked for a disclaimer on PRISM's website and outlined five major reasons he did not agree with PRISM. Tom Wilson, an editorial board member of an Elsevier journal, resigned, saying, "I cannot let my name continue to be associated with a publisher who is prepared to use this kind of tactic." Nature's Timo Hannay says the only reason its journals cannot be open access is that they have yet to find a viable economic model to support it.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.